SRPT - Company ID 0000873303
Sarepta Therapeutics, Inc. (SRPT) reported net income of -$713.41M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$713.41M | -403.3% |
| FY 2024 | $235.24M | +143.9% |
| FY 2023 | -$535.98M | +23.8% |
| FY 2022 | -$703.49M | -68.0% |
| FY 2021 | -$418.78M | +24.4% |
| FY 2020 | -$554.13M | +22.5% |
| FY 2019 | -$715.08M | -97.6% |
| FY 2018 | -$361.92M | -614.0% |
| FY 2017 |
Sarepta Therapeutics, Inc. (SRPT) reported net income of -$713.41M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, Sarepta Therapeutics, Inc.'s net income declined from -$2.32M to -$713.41M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$50.69M |
| +81.0% |
| FY 2016 | -$267.26M | -21.5% |
| FY 2015 | -$220.03M | -62.0% |
| FY 2014 | -$135.79M | -21.3% |
| FY 2013 | -$111.98M | +7.7% |
| FY 2012 | -$121.29M | -5132.4% |
| FY 2011 | -$2.32M | - |